Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neural Dissimilarity: A Promising New fMRI-based Measure of Smell? Changes in the Olfactory System Following Treatment for Severe CRSwNP With Monoclonal Antibodies

NCT07819162 is registered in ClinicalTrials.gov with Copenhagen University Hospital, Rigshospitalet as lead sponsor.

NCT NCT07819162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07819162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neural Dissimilarity: A Promising New fMRI-based Measure of Smell? Changes in the Olfactory System Following Treatment for Severe CRSwNP With Monoclonal Antibodies
Lead sponsor
Copenhagen University Hospital, Rigshospitalet
Phase
Observational
Overall status
Not yet recruiting
Start date
June 30, 2027
Completion date
June 30, 2029
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic rhinosinusitis with nasal polyps (crswnp), functional magnetic resonance imaging (fmri), olfactory dysfunction